Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Are We Asking About Tirzepatide? Emerging Oral Health Implications for Oral Medicine Practice
Oral diseases, 2026
Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review
Diabetes technology & therapeutics, 2026;:15209156261486127
Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2026
Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis
Cell reports. Medicine, 2026;:103023
The Evolution of Medications for Obesity Management
JGH open : an open access journal of gastroenterology and hepatology, 2026;10(9):e70466
Tirzepatide preserves hematopoietic stem and progenitor cycling while remodeling inflammatory monocytes in obese mice
bioRxiv : the preprint server for biology, 2026
From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals
Current medical research and opinion, 2026;:1-15
Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review
JAMA otolaryngology-- head & neck surgery, 2026
Obesity, fasting, and chronic migraine: Can semaglutide disrupt the vicious cycle?
Headache, 2026
Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study
Diabetes, obesity & metabolism, 2026
Semaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities
Pharmaceutical research, 2026
Tirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases
JCEM case reports, 2026;4(10):luag216
Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions
Clinics in dermatology, 2026
Beyond Weight Loss: Disentangling the Direct Effects of Semaglutide vs Equivalent Calorie Restriction on Reproductive Systems of Male and Female Rats
Molecular metabolism, 2026;:102436
(Un)intended consequences of mass-prescribing GLP-1s
Science (New York, N.Y.), 2026;393(6815):953
Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Frontiers in pharmacology, 2026;17:1916932
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome
Frontiers in endocrinology, 2026;17:1881392
Semaglutide Attenuates Inflammatory Macrophage Polarization and Promotes Changes Associated with Mitochondrial Biogenesis Through cAMP-Dependent Signaling
Biomedicines, 2026;14(9)
Impact of Glucagon-Like Peptide-1 Receptor Agonists on Mental Health: A Systematic Review of Psychiatric Safety and Antidepressant Potential
Cureus, 2026;18(9):e115703
Current therapeutic landscape and future treatment perspectives of MASH
Nature, 2026;657(8130):76-91